Hydralazine hydrochloride; hydrochlorothiazide; reserpine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydralazine hydrochloride; hydrochlorothiazide; reserpine and what is the scope of patent protection?
Hydralazine hydrochloride; hydrochlorothiazide; reserpine
is the generic ingredient in twelve branded drugs marketed by Chartwell Rx, Ivax Sub Teva Pharms, Mylan, Watson Labs, Sandoz, Solvay, Sun Pharm Industries, Lederle, and Novartis, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.Summary for hydralazine hydrochloride; hydrochlorothiazide; reserpine
US Patents: | 0 |
Tradenames: | 12 |
Applicants: | 9 |
NDAs: | 16 |
Clinical Trials: | 1 |
DailyMed Link: | hydralazine hydrochloride; hydrochlorothiazide; reserpine at DailyMed |
Recent Clinical Trials for hydralazine hydrochloride; hydrochlorothiazide; reserpine
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
US Department of Veterans Affairs | |
VA Office of Research and Development |
See all hydralazine hydrochloride; hydrochlorothiazide; reserpine clinical trials